Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.
Nick Moakes of the Wellcome Trust told the Sohn Hearts & Minds conference that some investors were too optimistic about a reduction in rates. Picture: Ben Searcy

Jonathan Shapiro, Joshua Peach and Daniel Arbon

Trump unifies top investors in decade-long bullish outlook for US

November 20, 2024
Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.
Read Transcript

Donald Trump has unified the world’s biggest investors with his plan to slash red tape and taxes, setting the US economy up for what Oaktree Capital’s Howard Marks described as a decade of peerless returns.

“Warren Buffett said it: don’t bet against the United States. He’s probably right about that,” the Wall Street veteran told the Sohn Hearts & Minds investment conference in Adelaide on Friday.

“The US economy is the envy of the world, and likely to stay that way.”

‍Trump’s win at last week’s presidential election over Democrat rival Kamala Harris has already led to a surge in US stocks. It has also sent the price of bitcoin surging, up about 30 per cent to touch a record above $US90,000.

Throughout the day at the charity conference, Australian and international fund managers pitched their best share market tips over the coming 12 months. Of the 11 stocks presented, five were listed in the US, two in Australia, two in China and two in Europe.

Mike Novogratz, the billionaire former president of Fortress Investment Group, said the Trump administration would “ignite a renaissance” in cryptocurrencies. Mr Novogratz, now the chief executive of specialist investment bank Galaxy Digital, told the conference he was “one of the few crypto guys that wasn’t a pro-Trump”.

“But I woke up and said, ‘Wow, this is going to make my business more fun’,” he said.

The pending return of Trump to the White House has upended global markets. During the election campaign, Trump made a number of pledges, including steep tariffs on Chinese imports and spending measures that would add billions of dollars to debts and likely fuel higher inflation.

The surge in US stocks has filtered into the returns of Australia’s big superannuation funds, which have allocated about a third of their assets to US-dominated global markets. A dollar invested in the US five years ago would now be worth over $2.20, compared to $1.17 in Australia.

Howard Marks beamed in from Beijing to the Sohn Hearts & Minds conference in Adelaide on Friday. Picture: Ben Searcy

On Thursday, Future Fund chief executive Raphael Arndt said Trump’s tax, deregulation and trade plans would accelerate both inflation and growth. “Like every investor, we’ve made money off the US election,” he said. “That’s actually a reasonably positive picture for an investor like Australia.”

For investors, there are now new questions about how high stocks will go. Peter Cooper, who oversees an $11 billion portfolio at Cooper Investments, said: “It’s been a brilliant success story in economic terms and in terms of stock market terms … the worry is: can America actually keep it going?”

Oaktree’s Mr Marks made a similar point. The valuations of stocks in New York were already high, he said: “You’re getting a great deal of merit, but you’re paying for it. You’re not getting that excellence for nothing.”

Ajay Rajadhyaksha, chairman of research at Barclays, the British bank that is now a minority investor in Barrenjoey, told the Sohn conference that the US was in an “incredibly strong macro position” to cement its status as a financial and technological superpower.

But he cautioned that the market may be overestimating the ability of the Trump administration to implement its policies. “There’s far more checks and balances within the US system of government than people sometimes realise, especially for the domestic economy,” he said.

New tariffs – and a trade war with China – would be a “much worse thing for the rest of the world than it is for the US”, Mr Rajadhyaksha added.

Mr Marks, who was speaking from Beijing, also warned that Trump would “come out swinging” against China, Australia’s largest trading partner.

“Trump is an avowed China basher, and the one thing that there’s consistency on in the US now is that it’s a winning strategy,” he said.

Mr Marks added that while Australia would continue to benefit from its relationships with both the US and China, from a geopolitical perspective it may be forced to pick a side. “If the situation evolves into real hostilities, and, of course, military hostilities – then, of course, Australia would have to choose. My hope is that it won’t.”

Treasurer Jim Chalmers this week warned that economic growth in Australia could suffer because of Trump’s policies, and his concerns were echoed by Treasury Secretary Steven Kennedy, Reserve Bank of Australia governor Michele Bullock, and two of the country’s top bank bosses last week.

AMP chief economist Shane Oliver said Australia’s $2.5 trillion economy would be worse off as a result of Trump’s policies. “Assuming Trump goes all the way with tariffs, then you could be looking at, in the first year or so, a 0.5 per cent hit to economic activity here,” he said.

While shares have soared since Trump’s election, bond market investors have had a more difficult time. Long-term bond rates have drifted higher as traders factor in the prospect of higher growth and inflation. The US 10-year rate has jumped from 3.62 per cent in mid-September to 4.45 per cent, while the Australian equivalent has risen from 3.83 per cent to 4.65 per cent.

Nick Moakes, the chief investment officer of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

In 2018 and 2021, the Wellcome Trust issued 100-year bonds at rates of just 2.5 per cent and 1.5 per cent, locking in funding at historically low rates.

“The bonds that we’ve issued all trade now with an interest rate of, roughly speaking, 5 per cent, and that’s much more realistic,” Mr Moakes said. “That’s a world that we all need to get used to, and it’s got implications for everything. It’s got implications for private equity, it’s got implications for discount rates that you use to value stocks.”

This article was originally posted by The Australian Financial Review here. 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by the Harry Perkins Institute of Medical Research, published on 3 October 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Donald Trump has unified the world’s biggest investors with his plan to slash red tape and taxes, setting the US economy up for what Oaktree Capital’s Howard Marks described as a decade of peerless returns.

“Warren Buffett said it: don’t bet against the United States. He’s probably right about that,” the Wall Street veteran told the Sohn Hearts & Minds investment conference in Adelaide on Friday.

“The US economy is the envy of the world, and likely to stay that way.”

‍Trump’s win at last week’s presidential election over Democrat rival Kamala Harris has already led to a surge in US stocks. It has also sent the price of bitcoin surging, up about 30 per cent to touch a record above $US90,000.

Throughout the day at the charity conference, Australian and international fund managers pitched their best share market tips over the coming 12 months. Of the 11 stocks presented, five were listed in the US, two in Australia, two in China and two in Europe.

Mike Novogratz, the billionaire former president of Fortress Investment Group, said the Trump administration would “ignite a renaissance” in cryptocurrencies. Mr Novogratz, now the chief executive of specialist investment bank Galaxy Digital, told the conference he was “one of the few crypto guys that wasn’t a pro-Trump”.

“But I woke up and said, ‘Wow, this is going to make my business more fun’,” he said.

The pending return of Trump to the White House has upended global markets. During the election campaign, Trump made a number of pledges, including steep tariffs on Chinese imports and spending measures that would add billions of dollars to debts and likely fuel higher inflation.

The surge in US stocks has filtered into the returns of Australia’s big superannuation funds, which have allocated about a third of their assets to US-dominated global markets. A dollar invested in the US five years ago would now be worth over $2.20, compared to $1.17 in Australia.

Howard Marks beamed in from Beijing to the Sohn Hearts & Minds conference in Adelaide on Friday. Picture: Ben Searcy

On Thursday, Future Fund chief executive Raphael Arndt said Trump’s tax, deregulation and trade plans would accelerate both inflation and growth. “Like every investor, we’ve made money off the US election,” he said. “That’s actually a reasonably positive picture for an investor like Australia.”

For investors, there are now new questions about how high stocks will go. Peter Cooper, who oversees an $11 billion portfolio at Cooper Investments, said: “It’s been a brilliant success story in economic terms and in terms of stock market terms … the worry is: can America actually keep it going?”

Oaktree’s Mr Marks made a similar point. The valuations of stocks in New York were already high, he said: “You’re getting a great deal of merit, but you’re paying for it. You’re not getting that excellence for nothing.”

Ajay Rajadhyaksha, chairman of research at Barclays, the British bank that is now a minority investor in Barrenjoey, told the Sohn conference that the US was in an “incredibly strong macro position” to cement its status as a financial and technological superpower.

But he cautioned that the market may be overestimating the ability of the Trump administration to implement its policies. “There’s far more checks and balances within the US system of government than people sometimes realise, especially for the domestic economy,” he said.

New tariffs – and a trade war with China – would be a “much worse thing for the rest of the world than it is for the US”, Mr Rajadhyaksha added.

Mr Marks, who was speaking from Beijing, also warned that Trump would “come out swinging” against China, Australia’s largest trading partner.

“Trump is an avowed China basher, and the one thing that there’s consistency on in the US now is that it’s a winning strategy,” he said.

Mr Marks added that while Australia would continue to benefit from its relationships with both the US and China, from a geopolitical perspective it may be forced to pick a side. “If the situation evolves into real hostilities, and, of course, military hostilities – then, of course, Australia would have to choose. My hope is that it won’t.”

Treasurer Jim Chalmers this week warned that economic growth in Australia could suffer because of Trump’s policies, and his concerns were echoed by Treasury Secretary Steven Kennedy, Reserve Bank of Australia governor Michele Bullock, and two of the country’s top bank bosses last week.

AMP chief economist Shane Oliver said Australia’s $2.5 trillion economy would be worse off as a result of Trump’s policies. “Assuming Trump goes all the way with tariffs, then you could be looking at, in the first year or so, a 0.5 per cent hit to economic activity here,” he said.

While shares have soared since Trump’s election, bond market investors have had a more difficult time. Long-term bond rates have drifted higher as traders factor in the prospect of higher growth and inflation. The US 10-year rate has jumped from 3.62 per cent in mid-September to 4.45 per cent, while the Australian equivalent has risen from 3.83 per cent to 4.65 per cent.

Nick Moakes, the chief investment officer of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

In 2018 and 2021, the Wellcome Trust issued 100-year bonds at rates of just 2.5 per cent and 1.5 per cent, locking in funding at historically low rates.

“The bonds that we’ve issued all trade now with an interest rate of, roughly speaking, 5 per cent, and that’s much more realistic,” Mr Moakes said. “That’s a world that we all need to get used to, and it’s got implications for everything. It’s got implications for private equity, it’s got implications for discount rates that you use to value stocks.”

This article was originally posted by The Australian Financial Review here. 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by the Harry Perkins Institute of Medical Research, published on 3 October 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 20, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
October 16, 2023

How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Read More
IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
October 6, 2023

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Read More
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.
September 18, 2023

‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.